The Global Implanted Infusion Pump Market was valued at USD 115 million in 2023 and is projected to reach USD 165.10 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.10% during the forecast period (2023-2032). This growth is propelled by increasing prevalence of chronic diseases requiring long-term medication, technological advancements in implantable devices, and growing preference for minimally invasive treatment solutions.
As healthcare shifts toward personalized and continuous therapeutic approaches, implanted infusion pumps have become critical tools for managing chronic pain, cancer therapies, diabetes, and neurological disorders. These devices enable targeted medication delivery while improving patient mobility and quality of life. This analysis highlights the Top 10 Companies in the Implanted Infusion Pump Industry—innovators driving advancements in safety, reliability, and therapeutic precision.
🔟 1. Medtronic plc
Headquarters: Dublin, Ireland
Key Offering: SynchroMed™ II, Isomed® systems
Medtronic dominates the market with its FDA-approved SynchroMed™ II implantable infusion system, holding approximately 60% of the global market share for pain management applications. Their programmable pump delivers precise medication doses to the cerebrospinal fluid for chronic pain and spasticity treatment.
Technology Highlights:
- Miniaturized designs for reduced implantation complexity
- Closed-loop systems integrating physiological sensors
- Full-body MRI compatibility
Download FREE Sample Report: Implanted Infusion Pump Market – View in Detailed Research Report
9️⃣ 2. Flowonix Medical
Headquarters: Mount Olive, New Jersey, USA
Key Offering: Prometra® II Programmable Pump
Flowonix specializes in precision drug delivery with its valve-gated Prometra® technology, demonstrating 99.9% dosing accuracy. The system is widely adopted for oncology pain management and features the industry’s longest refill intervals.
Clinical Advantages:
- 4-12 month refill cycles reducing patient visits
- Advanced error correction algorithms
- Multi-drug infusion capabilities
8️⃣ 3. Tricumed Medizintechnik GmbH
Headquarters: Kiel, Germany
Key Offering: CED (Convection-Enhanced Delivery) systems
Tricumed pioneers targeted brain tumor therapies with breakthrough CED technology that bypasses the blood-brain barrier, delivering chemotherapy directly to tumor sites with minimal systemic exposure.
Specialized Applications:
- Glioblastoma and CNS tumor treatments
- Neurodegenerative disease therapies
- Programmable flow rate configurations
7️⃣ 4. Codman & Shurtleff (Johnson & Johnson)
Headquarters: Raynham, Massachusetts, USA
Key Offering: Codman 3000 Constant Flow pump
This J&J subsidiary delivers reliable constant-flow infusion solutions for chemotherapy and analgesia, with a 55-year track record in ambulatory infusion therapy.
Design Features:
- Non-programmable for simplified operation
- Minimal maintenance requirements
- Cost-effective solution for stable dosing
Download FREE Sample Report: Implanted Infusion Pump Market – View in Detailed Research Report
6️⃣ 5. Abbott Laboratories
Headquarters: Chicago, Illinois, USA
Key Offering: Infinity™ implantable pump systems
Abbott’s MRI-compatible pumps feature advanced catheter technology and wireless monitoring, recently enhanced with Bluetooth connectivity for remote therapy management.
Innovations:
- AccuWave™ catheter positioning system
- Cloud-based therapy analytics
- Dual-chamber reservoir options
5️⃣ 6. Boston Scientific Corporation
Headquarters: Marlborough, Massachusetts, USA
Key Offering: Precision Spectra™ system
Boston Scientific integrates neuromodulation with drug delivery in its hybrid systems for chronic pain, featuring automated dosing adjustments based on patient response.
Integrated Technology:
- Combined electrical and pharmacological therapy
- Adaptive dosing algorithms
- Wearable patient controller
4️⃣ 7. Teleflex Incorporated
Headquarters: Wayne, Pennsylvania, USA
Key Offering: Arrow® implanted pumps
Teleflex provides cost-effective constant flow solutions primarily for post-surgical pain management in ambulatory settings, offering practical alternatives to hospital-based systems.
Market Position:
- Value-priced surgical center solutions
- Disposable pump options
- Short-term implantation protocols
3️⃣ 8. Pfizer Inc.
Headquarters: New York City, New York, USA
Key Offering: Removable infusion technologies
Pfizer advances removable pump solutions for oncology, allowing device extraction post-chemotherapy to reduce long-term infection risks associated with permanent implants.
Unique Features:
- Biodegradable components
- Outpatient implantation procedures
- 6-12 month treatment durations
2️⃣ 9. Becton, Dickinson and Company
Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: SmartSense™ implanted systems
BD’s AI-powered pumps monitor medication delivery and tissue response in real-time, automatically adjusting flow rates based on continuous physiological data analysis.
Digital Integration:
- Predictive maintenance alerts
- Mobile health application connectivity
- Automated refill scheduling
1️⃣ 10. Intarcia Therapeutics
Headquarters: Boston, Massachusetts, USA
Key Offering: ITCA 650 osmotic delivery system
Intarcia’s disruptive mini-pump technology delivers continuous subcutaneous medication for 6-12 months without external components, revolutionizing chronic disease management.
Breakthrough Design:
- No external ports or connectors
- Thermostable drug formulations
- Office-based insertion procedures